PROCEPT BioRobotics (PRCT) Misses Q4 EPS by 21c, Offers Guidance

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.53), $0.21 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $76.1 million versus the consensus estimate of $93.77 million.

GUIDANCE:

PROCEPT BioRobotics Corporation sees FY2026 revenue of $390-410 million, versus the consensus of $422 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• RenaissanceRe Holdings (RNR) PT Raised to $315 at TD Cowen
• Cal-Maine pays $1.5M in egg price-fixing deal as executives face no charges
• Goldman Sachs Starts InnoScience (Suzhou) Technology (2577:HK) at Buy